Company news
Pacific Biosciences of California, Inc. news in 2023
Pacific Biosciences of California, Inc.'s news releases, calls and decks from 2023, newest first.
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 26, 2023
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
December 10, 2023
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
November 1, 2023
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
October 31, 2023
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
October 30, 2023
PacBio Announces Third Quarter 2023 Financial Results
October 29, 2023
PacBio Announces Appointment of David Meline to Board of Directors
October 15, 2023
PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
October 11, 2023
PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
October 10, 2023
PacBio Announces PacBio Capital
September 11, 2023
PacBio Announces Collaboration with Leading Library Preparation Automation Partners
September 6, 2023
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
August 6, 2023
PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2023
PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
August 1, 2023
PacBio Begins Commercialization of the Onso Short-Read Sequencing System
August 1, 2023
PacBio Announces Second Quarter 2023 Financial Results
August 1, 2023
PacBio to Report Second Quarter 2023 Financial Results on August 2, 2023
July 18, 2023
PacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease
June 27, 2023
PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030
June 25, 2023
PacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research
June 13, 2023
PacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board
May 29, 2023
PacBio to Present at BofA Securities 2023 Health Care Conference
May 2, 2023
PacBio Announces Record Revenue in First Quarter 2023
May 1, 2023
PacBio to Report First Quarter 2023 Financial Results on May 2, 2023
April 17, 2023
PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems
April 4, 2023
PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System
March 27, 2023
PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes
March 13, 2023
PacBio To Begin Commercial Shipment of Revio Systems
March 6, 2023
PacBio to Present at Cowen's 43rd Annual Health Care Conference
February 26, 2023
PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
February 15, 2023
PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions
February 6, 2023
PacBio to Report Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
February 1, 2023
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
January 23, 2023
Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock
January 23, 2023
PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"
January 12, 2023
PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022
January 8, 2023
PacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration
January 8, 2023
Calls in 2023
- Pacific Biosciences of California (NASDAQ:PACB) Q3 2023 Earnings Call
Oct 30, 2023
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q2 2023 Earnings Call
Aug 2, 2023
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q1 2023 Earnings Call
May 2, 2023
Transcript - Pacific Biosciences of California (NASDAQ:PACB) Q4 2022 Earnings Call
Feb 16, 2023
Transcript